Aspire Biopharma Holdings ASBP
NASDAQ ASBP
$8.74 +0.02 (+0.23%)
As of: Oct 21, 2026 · 1:06 PM EDT

Aspire Biopharma Holdings, Inc. (ASBP) Total Non-Current Liabilities (2022 - 2025)

Updated

Aspire Biopharma Holdings' Total Non-Current Liabilities was $7.65 million in Q4 2025, up 543.3% from $1.19 million a year earlier.

Analysis

Aspire Biopharma Holdings, Inc. (ASBP) Total Non-Current Liabilities (2022 - 2025) Analysis & Trends

From Q4 2022 onward, Aspire Biopharma Holdings has reported Total Non-Current Liabilities for 9 quarters.

  • Total Non-Current Liabilities shows a three-year compound annual growth rate of -70.9% (FY2022 to FY2025).
  • In earlier years, Total Non-Current Liabilities was $1.19 million in FY2024 (-94.1%), $20.31 million in FY2023 (-93.4%) and $310.12 million in FY2022.
  • Quarterly Total Non-Current Liabilities has moved between $1.19 million (Q4 2024) and $310.12 million (Q4 2022) over five years.
  • Compared with a year earlier, Total Non-Current Liabilities was higher in two of the last four quarters, with growth averaging 103.0%.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 7.65 Mn
Jun 30, 2025 8.58 Mn
Mar 31, 2025 8.04 Mn
Dec 31, 2024 1.19 Mn
Jun 30, 2024 6.98 Mn
Mar 31, 2024 20.24 Mn
Dec 31, 2023 20.31 Mn
Sep 30, 2023 19.96 Mn
Dec 31, 2022 310.12 Mn
API Access

Aspire Biopharma Holdings, Inc. Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ASBP&period=max&api_key=YOUR_API_KEY